M&A Deal Summary

Fagron Acquires B&B Pharmaceuticals

On December 20, 2012, Fagron acquired medical products company B&B Pharmaceuticals

Acquisition Highlights
  • This is Fagron’s 7th transaction in the Medical Products sector.
  • This is Fagron’s 2nd transaction in the United States.
  • This is Fagron’s 1st transaction in Colorado.

M&A Deal Summary

Date 2012-12-20
Target B&B Pharmaceuticals
Sector Medical Products
Buyer(s) Fagron
Deal Type Add-on Acquisition

Target

B&B Pharmaceuticals

Aurora, Colorado, United States
B&B Pharmaceuticals, Inc. is a provider of pharmaceutical raw materials for pharmaceutical compounding to pharmacists in the United States.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Fagron

Nazareth, Belgium

Category Company
Founded 1990
Sector Medical Products
Employees3,282
Revenue 872M EUR (2024)
DESCRIPTION

Fagron is a provider of pharmaceutical raw materials, compounded products, repacked goods, packaging materials and pharmacy equipment. Fagron was founded in 1990 and is based in Nazareth, Belgium.


DEAL STATS #
Overall 7 of 16
Sector: Medical Products M&A 7 of 9
Type: Add-on Acquisition M&A Deals 6 of 14
State: Colorado M&A 1 of 1
Country: United States M&A 2 of 6
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-27 Pharma-Cosmetic K. M. Adamowicz s.j.

Cracow, Poland

Pharma-Cosmetic K. M. Adamowicz s.j. is a provider of pharmaceutical raw materials for compounding pharmacies in Poland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-25 Freedom Pharmaceuticals

Broken Arrow, Oklahoma, United States

Freedom Pharmaceuticals, Inc. is a provider of pharmaceutical raw materials, excipients, bases and capsules to independent compounding pharmacies throughout the United States.

Buy -